RenovoRx, Inc. (RNXT): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

-$10.51M

Year ended 2025-12-31

2024-12-31 EBITDA (USD) 2025-12-31

Period ended	EBITDA	Change YoY	Source filing
2025-12-31	-$10.51M	n/m	2026-03-30, From 2025-01-01
2024-12-31	-$10.97M	n/a	2026-03-30, From 2024-01-01

EBITDA at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	EBITDA	Change YoY
RenovoRx, Inc. (RNXT)	2025-12-31	-$10.51M	n/m
PetVivo Holdings, Inc. (PETV)	2026-03-31	-$8.55M	n/m
Catheter Precision, Inc. (VTAK)	2025-12-31	-$19.03M	n/m
EBR Systems, Inc. (NONE.)	2025-12-31	-$45.68M	n/m
Vycor Medical Inc (VYCO)	2025-12-31	$93.4K	+85.4%
Co-Diagnostics, Inc. (CODX)	2025-12-31	-$49.06M	n/m
Femasys Inc (FEMY)	2025-12-31	-$17.25M	n/m
QHSLab, Inc. (USAQ)	2025-12-31	$222.0K	-37.0%
Tenon Medical, Inc. (TNON)	2025-12-31	-$12.53M	n/m

Compare RNXT, PETV, VTAK, NONE. side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗